Hematopoietic Growth Factors in Oncology Image close
Hematopoietic Growth Factors in Oncology
Hematopoietic Growth Factors in Oncology
Show Hide Adult Content
Hematopoietic Growth Factors in Oncology close

Non-Fiction Books:

Home  
Books  
Non-Fiction  
Professional & Technical  
Medicine  
Clinical & internal medicine  
Haematology

Hematopoietic Growth Factors in Oncology

Basic Science and Clinical Therapeutics
Click to share your rating 0 ratings (0.0/5.0 average) Thanks for your vote!

Format:

Paperback / softback
$293.99
RRP:
$521.95 save $227.96
Available from supplier

The item is brand new and in-stock with one of our preferred suppliers. The item will ship from a Mighty Ape warehouse within the timeframe shown.

Usually ships in 3-4 weeks
0 in Trolley

Buy Now, Pay Later with:

4 payments of $73.50 with Afterpay Learn more

Availability

Delivering to:

Estimated arrival:

  • Around 27 Jun - 9 Jul using International Courier

Explore more Cancer Drug Discovery and Development

See all products in this series

Gene Therapy for Cancer on Hardback Save $36
$529.99
$566.95
Gene Therapy for Cancer
Hardback
Available - Usually ships in 3-4 weeks
Hematopoietic Growth Factors in Oncology on Hardback Save $154
$411.99
$566.95
Hematopoietic Growth Factors in Oncology
Hardback
Available - Usually ships in 3-4 weeks
Farnesyltransferase Inhibitors in Cancer Therapy on Hardback Save $50
$404.99
$455.95
Farnesyltransferase Inhibitors in Cancer Therapy
Hardback
Available - Usually ships in 3-4 weeks
Checkpoint Controls and Targets in Cancer Therapy Save $13
$401.99
$415.95
Checkpoint Controls and Targets in Cancer Therapy
Paperback / softback
Available - Usually ships in 3-4 weeks
Hypoxia and Cancer on Hardback Save $10
$404.99
$415.95
Hypoxia and Cancer
Hardback
Available - Usually ships in 3-4 weeks
Macromolecular Anticancer Therapeutics on Hardback
$713.99
Macromolecular Anticancer Therapeutics
Hardback
Available - Usually ships in 3-4 weeks
Apoptosis and Cancer Chemotherapy Save $168
$286.99
$455.95
Apoptosis and Cancer Chemotherapy
Paperback / softback
Available - Usually ships in 3-4 weeks
DNA Topoisomerases and Cancer
$519.99
DNA Topoisomerases and Cancer
Paperback / softback
Available - Usually ships in 3-4 weeks
Nitric Oxide (NO) and Cancer on Hardback Save $153
$526.99
$680.95
Nitric Oxide (NO) and Cancer
Hardback
Available - Usually ships in 3-4 weeks
DNA Topoisomerases and Cancer on Hardback
$521.99
DNA Topoisomerases and Cancer
Hardback
Available - Usually ships in 3-4 weeks
Advances in DNA Repair in Cancer Therapy on Hardback
$518.99
Advances in DNA Repair in Cancer Therapy
Hardback
Available - Usually ships in 3-4 weeks
Sensitization of Cancer Cells for Chemo/Immuno/Radio-therapy
$542.99
Sensitization of Cancer Cells for Chemo/Immuno/Radio-therapy
Paperback / softback
Available - Usually ships in 3-4 weeks
Protein Tyrosine Kinases on Hardback
$516.99
Protein Tyrosine Kinases
Hardback
Available - Usually ships in 3-4 weeks
COX-2 Blockade in Cancer Prevention and Therapy on Hardback Save $111
$409.99
$521.95
COX-2 Blockade in Cancer Prevention and Therapy
Hardback
Available - Usually ships in 3-4 weeks
PARP Inhibitors for Cancer Therapy on Hardback
$400.99
PARP Inhibitors for Cancer Therapy
Hardback
Available - Usually ships in 3-4 weeks
Checkpoint Controls and Targets in Cancer Therapy on Hardback Save $49
$406.99
$456.95
Checkpoint Controls and Targets in Cancer Therapy
Hardback
Available - Usually ships in 3-4 weeks

Description

Leading oncologists, hematologists, and nephrologists comprehensively review the role of HGFs in clinical practice, explain the molecular basis of their effects, and consider potential future developments. The authors focus on the use of HGFs in oncology, describing their cutting-edge application to patients with lung cancer, Hodgkin's and nonhodgkin's lymphoma, breast cancer, chronic lymphocytic leukemia, AIDS-related malignancies, myelodysplastic syndromes, and aplastic anemias. Among the HGFs described are granulocyte colony-stimulating factor, erythropoietc factors, thrombopoietic factors, and stem cell factor and its receptor, C-kit. To complete their survey, the contributors also consider the safety and economic implications of HGFs and the future potential for HGF antagonists in oncology.
Release date Australia
July 22nd, 2012
Audience
  • Professional & Vocational
Contributors
  • Edited by George Morstyn
  • Edited by Graham J. Lieschke
  • Edited by Maryann Foote
Edition
Softcover reprint of the original 1st ed. 2004
Illustrations
X, 477 p.
Pages
477
Dimensions
178x254x24
ISBN-13
9781468498479
Product ID
21577267

Customer reviews

Nobody has reviewed this product yet. You could be the first!

Write a Review

Marketplace listings

There are no Marketplace listings available for this product currently.
Already own it? Create a free listing and pay just 9% commission when it sells!

Sell Yours Here

Recommended for you

Recommended from your browsing history

Help & options

Filed under...

Books >
Non-Fiction >
Professional & Technical >
Medicine >
Clinical & internal medicine >
Haematology